Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Revance Therapeutics Inc. logo

Revance Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

4.92
 
USD
  
-0.02
  
(-0.40%)
Optionable: Yes  Market Cap: 415 M  90-day average vol: 1,838,829

Previous close: 4.94  Open: 5.0  Bid: 4.84  Ask: 5.13
52 week range    
4.57   
   37.98
Peers   
MNOV / 
JNJ / 
TENX / 
Last updated: Friday 29th March 2024
31
MarketXLS Rank
40
Value
15
Technical
39
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

RVNC Cash Flow

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in inventories-6 M-4 M-6 M-15 M
(Increase) Decrease in other current assets-2 M29000.0-151000.0-403000.0-2 M
(Increase) Decrease in other current liabilities-7 M51 M5 M29 M-2 M2 M-4 M
(Increase) Decrease in other working capital2 M335000.02 M-602000.02 M
(Increase) Decrease in payables-3 M-692000.0953000.03 M2 M-360000.04 M-2 M-5 M7 M
(Increase) Decrease in receivables80000.0-27 M27 M-2 M-2 M-8 M-16 M
Acquisitions-2 M-100000.0-100000.0-818000.0
AssetImpairmentCharge9 M3 M70 M93 M
CapitalExpenditureReported7 M3 M2 M3 M7 M3 M4 M10 M3 M7 M
Cash at beginning of period4 M172 M202 M64 M283 M74 M172 M337 M116 M115 M
Cash at end of period171 M202 M64 M283 M74 M172 M337 M116 M115 M145 M
Cash flow-55 M-56 M-60 M-95 M-104 M-106 M-179 M-222 M-194 M-217 M
CashFlowFromContinuingInvestingActivities-7 M-56 M-75 M119 M-107 M-18 M12 M-30 M-139 M110 M
ChangeInAccountPayable-3 M-692000.0953000.03 M2 M-360000.04 M-2 M-5 M7 M
ChangeInAccruedExpense2 M3 M8 M-565000.01 M4 M13 M7 M16 M-5 M
ChangeInInterestPayable2 M3 M8 M-565000.01 M
ChangeInPayablesAndAccruedExpense-1 M2 M8 M2 M3 M3 M18 M5 M10 M2 M
ChangeInPrepaidAssets-450000.08000.0-6 M5 M-3 M-1 M912000.0-2 M4 M-7 M
ChangeInWorkingCapital-10 M3 M3 M7 M23 M35 M41 M-2 M1 M-38 M
ChangesInAccountReceivables80000.0-27 M27 M-2 M-2 M-8 M-16 M
CommonStockPayments-742000.0-360000.0-340000.0
Depreciation2 M2 M1 M1 M2 M3 M10 M20 M34 M11 M
Depreciation unreconciled4 M3 M3 M2 M623000.0272000.020 M21 M39 M10 M
DepreciationAndAmortization4 M3 M3 M2 M623000.0272000.020 M21 M39 M10 M
FinancingCashFlow229 M143 M-3 M196 M2 M222 M331 M30 M332 M137 M
Free cash flow-62 M-59 M-61 M-98 M-110 M-109 M-183 M-232 M-197 M-223 M
GainLossOnInvestmentSecurities-4 M
GainLossOnSaleOfPPE38000.0-1000.0-1 M-8000.052000.0
IncomeTaxPaidSupplementalData3 M100000.0700000.0300000.0
InterestPaidSupplementalData1 M802000.0676000.0299000.016000.03 M5 M12 M15 M
Issuance of capital stock103 M10 M39 M11 M68 M22 M32 M100 M
Issuance of debt-6 M-3 M98 M48 M
IssuanceOfCapitalStock103 M10 M39 M11 M68 M22 M32 M100 M
IssuanceOfDebt-6 M-5 M-4 M-4 M-932000.0278 M87 M30 M
Net cash from financing activities229 M143 M-3 M196 M2 M222 M331 M30 M332 M137 M
Net cash from investing activities-7 M-56 M-75 M119 M-107 M-18 M12 M-30 M-139 M110 M
Net cash from operating activities-55 M-56 M-60 M-95 M-104 M-106 M-179 M-222 M-194 M-217 M
Net change in cash & cash equivalents167 M31 M-138 M219 M-209 M98 M165 M-221 M-652000.030 M
Net income from continuing operations-63 M-73 M-89 M-121 M-143 M-159 M-282 M-281 M-356 M-324 M
NetBusinessPurchaseAndSale-2 M-100000.0-100000.0-818000.0
NetCommonStockIssuance103 M10 M39 M10 M68 M22 M32 M100 M
NetIntangiblesPurchaseAndSale-118000.0
NetInvestmentPropertiesPurchaseAndSale75000.0-53 M-72 M121 M-101 M-14 M17 M-19 M-136 M117 M
NetInvestmentPurchaseAndSale75000.0-53 M-72 M121 M-101 M-14 M17 M-19 M-136 M117 M
NetIssuancePaymentsOfDebt-6 M-5 M-4 M-4 M-932000.0278 M87 M30 M
NetLongTermDebtIssuance-228000.0-3 M-4 M-4 M-932000.0278 M-11 M-18 M
NetPPEPurchaseAndSale-7 M-3 M-2 M-3 M-5 M-3 M-4 M-10 M-3 M-7 M
Operating (gains) losses4 M38000.0-1000.0-1 M-8000.052000.0
Other financing charges net132 M135 M-750000.0156 M-3 M211 M-22 M-9 M208 M-9 M
Other investing changes net75000.075000.0-8 M-20 M-5 M
Other non-cash items10 M12 M24 M17 M16 M18 M43 M41 M123 M136 M
ProceedsFromIssuanceOfWarrants-1 M
ProceedsFromStockOptionExercised2 M3 M2 M5 M5 M937000.07 M17 M5 M15 M
Purchase of Float term investments-53 M-73 M121 M-169 M-14 M196000.0-12 M-116 M122 M
Purchase of property plant & equipment-7 M-3 M-2 M-3 M-5 M-3 M-4 M-10 M-3 M-7 M
Purchase of short term investments288 M
PurchaseOfIntangibles-118000.0
PurchaseOfInvestment-53 M-73 M121 M-169 M-14 M196000.0-12 M-116 M122 M
PurchaseOfPPE-7 M-3 M-2 M-3 M-7 M-3 M-4 M-10 M-3 M-7 M
Repayment of debt-228000.0-3 M-4 M-4 M-932000.0-9 M-11 M-18 M
RepaymentOfDebt-13 M-5 M-4 M-4 M-932000.0-9 M-11 M-18 M
Repurchase of capital stock-742000.0-360000.0-340000.0
Revenue per share1 M645000.01 M410000.0-1 M-3 M9 M1 M5 M-2 M
Sale of short term investments1000000.067 M17 M
SaleOfInvestment1000000.067 M17 M
SaleOfPPE2000.02 M8000.0
ShortTermDebtIssuance7 M98 M48 M
ShortTermDebtPayments-12 M-3 M
StockBasedCompensation7 M12 M12 M13 M16 M18 M36 M43 M52 M48 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University